While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

In real-world cohort, percentage weight reduction at 1 year was 3.6%, 6.8%, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and ...

SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

Share on Pinterest Ozempic, the active ingredient of which is semaglutide ... which included having an urgent medical visit or hospitalization from heart failure and death from cardiovascular ...

Without effective interventions, the global burden of obesity and its complications will continue to rise,” said Stephen Gough, senior vice president and head of Chief Medical Office ... after ...

Using semaglutide injections ... senior vice president of clinical development, medical and regulatory affairs at Novo Nordisk, maker of Ozempic and Wegovy, in a press release provided to Fox ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared ... Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc. “We are pleased that the ...